Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in ...

Glenmark Pharmaceuticals on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the ...

Timex Group to sell 15% stake in Indian entity, Hindalco acquires AluChem, CCI approves Bain Capital's stake in Manappuram.

Glenmark Pharmaceuticals launches Tevimbra, a new lung cancer treatment drug, in India. This marks Glenmark's entry into ...

Glenmark Pharmaceuticals has launched the lung cancer drug Tevimbra in India after approval by the Central Drugs Standard Control Organisation. Developed by global oncology leader BeiGene, now BeOne ...

HDFC Mutual Fund has raised its stake in Glenmark Pharmaceuticals to 5.07 percent after acquiring 3.57 lakh shares, despite ...

Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Olopatadine Hydrochloride Ophthalmic ...

Glenmark Pharma launches Tevimbra in India to treat lung and esophageal cancer: Our Bureau, Mumbai Tuesday, June 24, 2025, 14:15 Hrs [IST] Glenmark Pharmaceuticals Ltd, a research ...

Glenmark said that the FDA has issued a Form 483 upon the conclusion of its inspection at the manufacturing facility. The ...

Glenmark Pharma said it would work in close collaboration with the agency to address the observations and will respond to the ...